Restoring Health and Hope
We are advancing our Tmod™ cell engineering platform to create precision CAR T-cell therapies. Our mission is to restore health and hope for people living with cancer and other devastating diseases.
Novel.
Differentiated.
Disruptive.
OUR SCIENCE
A2 Bio’s proprietary Tmod™ precision-targeting cell therapy platform has been rigorously tested pre-clinically and provides a foundation for both autologous and allogeneic applications.
Modular.
Flexible.
Expansive.
OUR PIPELINE
We are rapidly advancing our leading cell therapies through clinical trials and developing new innovations to address the most devastating diseases.
Advancing.
Experienced.
Focused.
OUR TEAM
We are driven with urgency to help patients. Our team members share a common commitment and decades of experience in advancing innovative cell therapies from discovery to manufacturing, clinical trials, regulatory approval and commercialization.